What Happened: A notable Form 4 filing on Monday with the U.S. Securities and Exchange Commission revealed that Meury, Chief Executive Officer at Incyte, exercised stock options for 0 shares of INCY, ...

Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...

Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

The medicinal cannabis purveyor Bioxyne was the top performing ASX biotech in 2024-25,  recording a 720% share gain.

Mesoblast Limited (NASDAQ:MESO) is one of the 7 Best ASX Stocks to Buy Now. The company announced that it received 7 years of orphan-drug exclusive approval from the US FDA for Ryoncil® (remestemcel-L ...

TikTok is a particularly valuable platform for helping find matches because it targets younger audiences, said Erica Jensen, ...

So, we marked another World Sickle Cell Day on Thursday, June 19. But truthfully, what was there to celebrate? I can’t speak ...

A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from ...

SEATTLE, WA, USA I June 27, 2025 I Omeros Corporation (Nasdaq: OMER) today announced the recent submission of a Marketing Authorization Application (MAA) to ...